scholarly journals Effects of acute caffeine, theanine and tyrosine supplementation on mental and physical performance in athletes

2019 ◽  
Vol 16 (1) ◽  
Author(s):  
Javier Zaragoza ◽  
Grant Tinsley ◽  
Stacie Urbina ◽  
Katelyn Villa ◽  
Emily Santos ◽  
...  
Keyword(s):  
Physical Performance ◽  
Linear Models ◽  
Dynamic Testing ◽  
Collegiate Athletes ◽  
Performance Testing ◽  
The Body ◽  
Double Blind ◽  
Movement Accuracy ◽  
Beneficial Effects ◽  
Before And After

Abstract Background A limited amount of research has demonstrated beneficial effects of caffeine and theanine supplementation for enhancement of mental performance. The purpose of this investigation was to determine whether the acute ingestion of a supplement containing caffeine, theanine and tyrosine improves mental and physical performance in athletes. Methods Twenty current or former male collegiate athletes (age: 20.5 ± 1.4 y; height: 1.82 ± 0.08 m; weight: 83.9 ± 12.6 kg; body fat: 13.8 ± 5.6%) completed this randomized, double-blind, placebo-controlled crossover trial. After familiarization, each participant completed two identical testing sessions with provision of a proprietary dietary supplement (SUP) containing caffeine theanine and tyrosine or a placebo (PL). Within each testing session, participants completed assessments of mental and physical performance before and after provision of SUP or PL, as well as after two rounds of exercise. Assessments were performed using a performance testing device (Makoto Arena) that evaluated multiple aspects of mental and physical performance in response to auditory and visual stimuli. Testing was performed both with the body in a static position and during dynamic movement. General linear models were used to evaluate the effects of SUP and PL on performance. Results Changes in movement accuracy during performance assessment were greater following SUP ingestion as compared to PL for both static and dynamic testing (SUP: + 0.4 to 7.5%; PL: − 1.4 to 1.4% on average; p < 0.05). For dynamic testing, the change in number of targets hit was higher and the change in average hit time was lower with SUP as compared to PL (p < 0.05). However, there were no differences between conditions for the changes in number of targets hit or average hit time during static testing. There were no differences in changes of subjective variables during either condition, and performance measures during the two rounds of exercise did not differ between conditions (p > 0.05). Discussion The present results indicate that a combination of a low-dose of caffeine with theanine and tyrosine may improve athletes’ movement accuracy surrounding bouts of exhaustive exercise without altering subjective variables. Based on this finding, supplementation with caffeine, theanine and tyrosine could potentially hold ergogenic value for athletes in sports requiring rapid and accurate movements. Trial registration NCT03019523. Registered 24 January 2017.

scholarly journals Soy-enriched bread, a pilot study to determine its beneficial effects in menopause

2021 ◽  
Author(s):  
Daniela Giustarini ◽  
Comasia Ricci ◽  
Ilaria Ceccarelli ◽  
Stefano Pieretti ◽  
Paolo Andre ◽  
...  
Keyword(s):  
Experimental Tests ◽  
The Body ◽  
Many Body ◽  
Beneficial Effects ◽  
Regular Consumption ◽  
Aging Women ◽  
Before And After ◽  
Quality Of Life Index ◽  
Antioxidant Parameters ◽  
History Of

Menopause is the last step in the reproductive history of a woman. The ovaries stop producing hormones and the body reacts by lowering its functions, including the neuronal one. Phytoestrogens are plant products with estrogen-like activity able to affect many body functions. The aim of the present experiment was to study the effects of 30 days of regular consumption of a soy-enriched bread containing a known amount of phytoestrogens (genistein and daidzein). Women at climacteric, within 5 years or more than 5 years of menopause, were asked to include in their diet 200 g/day of a bread containing 40 mg of phytoestrogens. The effect on common menopausal symptoms and neurophysiological, hormonal and antioxidant parameters were determined before and after 30 days through questionnaires and experimental tests. Phytoestrogens were measured in the urine. In all groups, there was a significant increase of phytoestrogens in the urine and a decrease of the classical symptoms of menopause as well as a significant improvement in attentional performance tests, the quality of life index and pain intensity. Phytoestrogens present in the soy-enriched bread, are an important supplement in aging women due to their ability to induce estrogen-like effects without the potential side effects of estrogens.

scholarly journals Exercise Induced Adipokine Changes and the Metabolic Syndrome

2014 ◽  
Vol 2014 ◽  
pp. 1-16 ◽  
Author(s):  
Saeid Golbidi ◽  
Ismail Laher
Keyword(s):  
Physical Activity ◽  
Insulin Resistance ◽  
Metabolic Syndrome ◽  
Adipose Tissue ◽  
The Body ◽  
Beneficial Effects ◽  
The Metabolic Syndrome ◽  
Before And After ◽  
Inflammatory State ◽  
Exercise Induced

The lack of adequate physical activity and obesity created a worldwide pandemic. Obesity is characterized by the deposition of adipose tissue in various parts of the body; it is now evident that adipose tissue also acts as an endocrine organ capable of secreting many cytokines that are though to be involved in the pathophysiology of obesity, insulin resistance, and metabolic syndrome. Adipokines, or adipose tissue-derived proteins, play a pivotal role in this scenario. Increased secretion of proinflammatory adipokines leads to a chronic inflammatory state that is accompanied by insulin resistance and glucose intolerance. Lifestyle change in terms of increased physical activity and exercise is the best nonpharmacological treatment for obesity since these can reduce insulin resistance, counteract the inflammatory state, and improve the lipid profile. There is growing evidence that exercise exerts its beneficial effects partly through alterations in the adipokine profile; that is, exercise increases secretion of anti-inflammatory adipokines and reduces proinflammatory cytokines. In this paper we briefly describe the pathophysiologic role of four important adipokines (adiponectin, leptin, TNF-α, and IL-6) in the metabolic syndrome and review some of the clinical trials that monitored these adipokines as a clinical outcome before and after exercise.

scholarly journals Effects of creatine hydrochloride supplementation on physical performance and hormonal changes in soldiers

2021 ◽  
Vol 9 (1) ◽  
pp. 93-99
Author(s):  
Mohammad Milad Tayebi ◽  
Mitra Yousefpour ◽  
Laya Ghahari
Keyword(s):  
Physical Performance ◽  
Vertical Jump ◽  
Hormonal Changes ◽  
Power Performance ◽  
Mean Power ◽  
Wingate Anaerobic Test ◽  
Double Blind ◽  
Back Squat ◽  
Before And After ◽  
Army Soldiers

Purpose: The aim of this study was to examine the effects of 2 weeks of creatine hydrochloride (CrHCl) supplementation on physical performance and hormonal changes in army soldiers. Materials: Eighteen male army soldiers were randomly assigned in a double-blind fashion to either a CrHCl (n=9) or placebo (Pl) (n=9) groups. CrHCl group costumed 3g of creatine per day, whereas Pl group was given dextrose. Before and after supplementation period, the subjects performed a battery of performance tests including one repletion maximum (1RM) of bench press and back squat, vertical jump (VJ) and Wingate anaerobic test. In addition, blood samples were obtained to determine changes in testosterone and cortisol concentrations per and post supplementation. Results: There were significant increases in VJ, peak and mean power, and 1RM back squat test following the 2 weeks of CrHCl supplementation (p < 0.05) without any significant change for the Pl group. In addition significant changes were observed in testosterone and cortisol concentrations from before to after supplementation in CrHCl group (p < 0.05) and compared with Pl group (p=0.001). Conclusions: In conclusion, the present study indicates that CrHCl supplementation can improve VJ, power performance, 1RM back squat and hormonal changes in army soldiers.

The benefit of a supplement with the antioxidant melatonin on redox status and muscle damage in resistance-trained athletes

2017 ◽  
Vol 42 (7) ◽  
pp. 700-707 ◽  
Author(s):  
Roberto C. Leonardo-Mendonça ◽  
Javier Ocaña-Wilhelmi ◽  
Tomás de Haro ◽  
Carlos de Teresa-Galván ◽  
Eduardo Guerra-Hernández ◽  
...  
Keyword(s):  
Oxidative Stress ◽  
Muscle Damage ◽  
Antioxidant Properties ◽  
Redox Status ◽  
Absorption Capacity ◽  
Double Blind ◽  
Beneficial Effects ◽  
Before And After ◽  
High Doses ◽  
Exercise Induced

Previous data showed that the administration of high doses of melatonin improved the circadian system in athletes. Here, we investigated in the same experimental paradigm whether the antioxidant properties of melatonin has also beneficial effects against exercise-induced oxidative stress and muscle damage in athletes. Twenty-four athletes were treated with 100 mg·day−1 of melatonin or placebo 30 min before bedtime during 4 weeks in a randomized double-blind scheme. Exercise intensity was higher during the study that before starting it. Blood samples were collected before and after treatment, and plasma was used for oxygen radical absorption capacity (ORAC), lipid peroxidation (LPO), nitrite plus nitrate (NOx), and advanced oxidation protein products (AOPP) determinations. Glutathione (GSH), glutathione disulphide (GSSG) levels, and glutathione peroxidase (GPx) and reductase (GRd) activities, were measured in erythrocytes. Melatonin intake increased ORAC, reduced LPO and NOx levels, and prevented the increase of AOPP, compared to placebo group. Melatonin was also more efficient than placebo in reducing GSSG·GSH−1 and GPx·GRd−1 ratios. Melatonin, but not placebo, reduced creatine kinase, lactate dehydrogenase, creatinine, and total cholesterol levels. Overall, the data reflect a beneficial effect of melatonin treatment in resistance-training athletes, preventing extra- and intracellular oxidative stress induced by exercise, and yielding further skeletal muscle protection against exercise-induced oxidative damage.

Changes in Brain-Derived Neurotrophic Factor Following Treatment with Mifepristone in Bipolar Disorder and Schizophrenia

2007 ◽  
Vol 41 (4) ◽  
pp. 321-326 ◽  
Author(s):  
Paul Mackin ◽  
Peter Gallagher ◽  
Stuart Watson ◽  
Allan H. Young ◽  
I. Nicol Ferrier
Keyword(s):  
Bipolar Disorder ◽  
Neurotrophic Factor ◽  
Brain Derived Neurotrophic Factor ◽  
Crossover Design ◽  
Healthy Controls ◽  
Double Blind ◽  
Beneficial Effects ◽  
Before And After ◽  
Patient Groups ◽  
Cortisol Levels

Objective: Brain-derived neurotrophic factor (BDNF) is stress-responsive and has been implicated in a number of disparate neuropsychiatric disorders. Glucocorticoid antagonists have been shown to have beneficial effects on mood and cognitive function in bipolar disorder but not in schizophrenia. The aim of the present study was to investigate BDNF levels in patients with bipolar disorder and schizophrenia before and after treatment with the glucocorticoid receptor antagonist mifepristone. Methods: Peripheral BDNF levels were measured in patients with bipolar disorder (n=20), schizophrenia (n=20) and 14 matched healthy controls following 7 days of adjunctive mifepristone (600 mg day−1) treatment in a double-blind, placebo-controlled crossover design study. Results: Baseline BDNF values were similar in both patient groups and in healthy controls. Following treatment with mifepristone, cortisol levels were significantly increased and BDNF levels decreased in both schizophrenia and bipolar disorder. A significant correlation existed between change in cortisol level and change in BDNF levels following mifepristone treatment in schizophrenia, but not in bipolar disorder. Conclusion: Differing BDNF responses to increasing cortisol levels between patients with schizophrenia and with bipolar disorder may reflect underlying pathophysiological mechanisms.

scholarly journals Effect of Probiotic Supplementation Along With Calorie Restriction on Metabolic Endotoxemia, and Mega Inflammation in Coronary Artery Disease Patients: A Double Blind Placebo Controlled Randomized Clinical Trial

2020 ◽  
Author(s):  
jalal moludi ◽  
Hossein Samadi Kafil ◽  
Pourya Gholizadeh ◽  
Mohammad Alizadeh ◽  
Hamed Jafari Vayghyan
Keyword(s):  
Lactobacillus Rhamnosus ◽  
Serum Levels ◽  
Interleukin 10 ◽  
Preliminary Evidence ◽  
Probiotic Supplementation ◽  
Double Blind ◽  
Beneficial Effects ◽  
Before And After ◽  
Artery Disease ◽  
Metabolic Endotoxemia

Abstract Purpose: Dysbiosis has been associated with increased microbial translocation, leading to chronic inflammation in cardiovascular diseases (CVD). It has been proposed that modulation of gut microbiota by probiotic might modify metabolic endotoxemia. Therefore, the purpose of this study was to examine the effects of Lactobacillus rhamnosus GG (LGG) on metabolic endotoxemia, and marker of inflammation in CVD subjects. Methods: This study was a 12-weeks randomized, double-blind, and intervention on 44 patients with CVD. Patients were randomly allocated to receive either one LGG capsule 1.6 ×109 colony-forming unit (CFU) or the placebo capsules for 12 weeks. Serum levels of interleukin-1β (IL-1β), Toll-like receptor 4 (TLR4), interleukin-10 (IL-10), and lipopolysaccharide (LPS), were assessed before and after the intervention. Results: A significant decrease in IL1-Beta concentration (-1.88 ± 2.25, vs. 0.56 ± 1.58 mmol/L, P=0.027), and LPS levels (-5.20 ±2.70 vs. 2.96+ 5.27 mg/L, P=0.016), was observed after the probiotic supplementation compared with the placebo. Subjects who had ≥2.5 kg weight loss showed significantly improved in some variables, compared to patients with <2.5 kg weight reduction, regardless of the supplement they receive.Conclusion: These data provide preliminary evidence that probiotic supplementation has beneficial effects on metabolic endotoxemia, and mega inflammation in subjects with CVD.

scholarly journals Bioavailability of a Novel Form of Microencapsulated Bovine Lactoferrin and Its Effect on Inflammatory Markers and the Gut Microbiome: A Pilot Study

Nutrients ◽  
2018 ◽  
Vol 10 (8) ◽  
pp. 1115 ◽  
Author(s):  
Clare Dix ◽  
Olivia Wright
Keyword(s):  
Gut Microbiome ◽  
Bovine Lactoferrin ◽  
Metagenomic Sequencing ◽  
Serum Samples ◽  
Double Blind ◽  
16S Sequencing ◽  
Cd8 Cells ◽  
Beneficial Effects ◽  
Positive Effects ◽  
Before And After

Bovine lactoferrin, extracted from milk or whey, is used in a range of products to enhance immunity and support digestive health, iron absorption, and homeostasis. This study examined the absorption and effect of Progel (Brisbane, Queensland, Australia) microencapsulated bovine lactoferrin (InferrinTM, Bega Bionutrients, Victoria, Australia) on immune markers and the microbiome. A double-blind randomised, cross-over trial was conducted with 12 healthy males randomised to one of two doses, equivalent to 200 mg or 600 mg lactoferrin, for two four-week supplementation arms, with a two-week washout period. Subjects received either standard bovine lactoferrin or InferrinTM for each arm. Baseline and post each trial arm, CD69+ activation on CD4+ and CD8+ cells was analysed, bovine and human lactoferrin contents of faecal and serum samples were reported, and the gut microbiome was analysed using 16S sequencing and metagenomic sequencing. The mean level of CD69+ activation on the CD4+ cells was lower after supplementation regardless of the form or dose of lactoferrin. This was statistically significant for the 200 mg dose. A higher level of bovine lactoferrin was found post-supplementation in those taking InferrinTM, although this was not statistically significant. Changes in phylum-level microbial community profiling were detected post-supplementation in the second trial arm, particularly in those receiving InferrinTM. Metagenomic sequencing showed changes in the volumes of the top 100 species of bacteria present before and after all treatment arms. Results suggest that lactoferrin supplementation may have beneficial effects on the microbiome and immune system, and that the use of InferrinTM improves absorption. Larger detailed studies are needed to ascertain the potential positive effects of bovine lactoferrin supplementation.

scholarly journals BENEFICIAL EFFECTS OF TREATMENT WITH TOCILIZUMAB IN MODERATE TO CRITICALLY ILL COVID-19 PATIENTS

2021 ◽  
Vol 2021 (1) ◽  
Author(s):  
MA Rana ◽  
MS Hashmi ◽  
R Pervaiz ◽  
A Qayyum ◽  
MMU Saif ◽  
...  
Keyword(s):  
Critically Ill ◽  
Serum Ferritin ◽  
The Body ◽  
Rank Test ◽  
P Value ◽  
Beneficial Effects ◽  
Before And After ◽  
Interleukin 6 Receptor ◽  
Clinical Benefits ◽  
Signed Rank Test

Introduction: COVID-19 virus initiates an inflammatory response in the body involving many cytokines. Interluukin-6 (IL-6) is one of them, elevated levels of which found to be directly related to morbidity and mortality of infected patients. The aim of the current study was to evaluate the clinical benefits of Tocilizumab, a monoclonal antibody against interleukin-6 receptor, as a therapeutic agent for the treatment of Coronavirus disease 2019. Methods: The current retrospective study was conducted at Bahria Town International hospital from rom May 1st to 5th July 2020. Total of one twenty (n=120) moderate to severely ill patients (94 males and 26 females), infected with SARS-CoV-2 virus, were included to assess the effect of TOCILIZUMAB in improvement of PF ratio and other biochemical variables of prognostic importance, including CRP, serum ferritin levels, D-dimers and LDH. These parameters were compared before and after the ten days of treatment with tocilizumab. Demographic, laboratory and clinical finding were recorded for the feather analyses.  Statistical analysis was performed by using software SPSS version 21.0. The Wilcoxon signed‐rank test used to compare parameters whenever appropriate. A P‐value of less than .05 was considered statistically significant. Results: The results of our study showed statistically significant improvement in PF ratio and decrease in CRP levels. Other parameters such as D-Dimer, Serum ferritin levels and LDH showed no change before and after treatment with tocilizumab. Conclusion: In summary, TOCILIZUMAB improved the PF and CRP ratio in COVID-19 patients, but other markers did not improve in response to TOCILIZUMAB in critically ill COVID-19 patients.

scholarly journals Effectiveness of Paranasal Air Suction on Acute Migraine Using Portable Air Sucker – A Randomized, Double Blind Study

2021 ◽  
Author(s):  
SMR bandara ◽  
S samita ◽  
AM kiridana ◽  
HMMTB herath
Keyword(s):  
Clinical Trial ◽  
Side Effects ◽  
Primary Headache ◽  
Headache Disorder ◽  
Low Pressure ◽  
The Body ◽  
Control Group ◽  
Double Blind ◽  
Primary Headache Disorder ◽  
Before And After

Abstract Background Migraine is a primary headache disorder and is the most common disabling primary headache disorder that occurs in children and adolescents. A recent study showed that paranasal air suction can provide relief to migraine headache. However, in order to get the maximum benefit out of it, an easy to use effective air sucker should be available. Aiming to fulfil the above requirement, a randomized, double blind control clinical trial was conducted to investigate the efficacy of a recently developed low–pressure portable air sucker.Methods Eighty-six Sri Lankan school children of age 16–19 years with migraine were used for the study. They were randomly allocated into two groups, and one group was subjected to six intermittent ten-second paranasal air suctions using the portable air sucker for 120 seconds. The other group was subjected to placebo air suction (no paranasal air suction). The effect of suction was the key concern but effect of side of headache, type of headache, and gender were also studied with respect to number of response variables. The key response studied was severity of headache. In addition, left and right supraorbital tenderness, photophobia, phonophobia, numbness over the face and scalp, nausea and generalized tiredness/weakness of the body were studied. The measurements on all those variables were made before and after suction, and the statistical analysis was performed based on before and after differences. As a follow–up, patients were monitored for 24-hour period.Results There was a significant reduction in the severity of headache and other migraine symptoms in the treatment group compared to the control group two minutes after the suction. These symptoms did not recur within 24-hour period and there were no significant side effects recorded during the 24-hour observation period.Conclusion This pilot study showed that low–pressure portable air sucker is effective in paranasal air suction, and suction for 120 seconds using the sucker can provide an immediate relief which can last for more than 24-hour period without any side effects.Trail registration Clinical Trial Government Identification Number – 1548/2016.

scholarly journals Resistant maltodextrin intake reduces virulent metabolites in the gut environment: randomized control study in a Japanese cohort

2020 ◽  
Author(s):  
Yuichiro Nishimoto ◽  
Yoshinori Mizuguchi ◽  
Yuka Mori ◽  
Masaki Ito ◽  
Shoko Miyazato ◽  
...  
Keyword(s):  
Controlled Trial ◽  
Causative Factor ◽  
Intestinal Microbiome ◽  
Rrna Gene ◽  
Double Blind ◽  
Intestinal Environment ◽  
Beneficial Effects ◽  
Japanese Cohort ◽  
Before And After ◽  
Resistant Maltodextrin

AbstractObjectiveIn recent years, there have been many reports on the effects of prebiotics on intestinal health. In particular, consuming resistant maltodextrin (RMD) has been reported to be beneficial. However, there has been no comprehensive quantification of the effect of RMD on the intestinal environment. Therefore, this study aimed to quantify the effects of RMD on the intestine, especially the intestinal microbiome and metabolome profiles.DesignA randomized, double-blind controlled trial was conducted in 29 Japanese subjects with relatively high hemoglobin A1c (HbA1c). Subjects consumed RMD or placebo twice per day for 24 weeks. Blood and fecal samples were collected before and after intake. The intestinal environment was assessed by a metabologenomics approach combined with 16S rRNA gene-based microbiome and mass spectrometry-based metabologenomics analyses.ResultsThe intake of RMD increased the levels of Bifidobacterium and Fusicatenibacter, and decreased deoxycholate. In addition, intake of the RMD lowered the levels of some virulent metabolites, such as imidazole propionate and trimethylamine, in subjects with an initially high amount of those metabolites.ConclusionRMD may have beneficial effects on the gut environment such as commensal microbiota modulation and reduction of virulence metabolites, known as a causative factor in metabolic disorders. However, its effect partially depends on the gut environmental baseline.

Sign in / Sign up

Export Citation Format

Share Document